In fact, the clinical study showing the relevance of exosomes expressing PSA in prostate cancer diagnosis suggests that future clinical investigation should also be aimed at verifying a potential new role of the old tumor biomarkers when expressed on exosomes. The gene discussed is KLK3; the disease is prostate carcinoma.